Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
Xuehua Zhang, Leilei Zhao, He Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
Jun Yang, Yong Li, Shaoping Jiang, et al.
Exploration (2024)
Open Access | Times Cited: 20
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives
Ilaria Salvato, Antonio Marchini
Cancers (2024) Vol. 16, Iss. 7, pp. 1276-1276
Open Access | Times Cited: 17
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
Frank Eckerdt, Leonidas C. Platanias
Cancers (2023) Vol. 15, Iss. 13, pp. 3458-3458
Open Access | Times Cited: 36
Nanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review
Anup K. Ghosh, Aparajita Ghosh, Prasanta Kumar Das
ACS Applied Nano Materials (2024) Vol. 7, Iss. 3, pp. 2430-2460
Closed Access | Times Cited: 12
Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma
Hao Zhang, Ying Hong, Tingting Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Nanoparticle-based Drug Delivery Systems to Modulate Tumor Immune Response for Glioblastoma Treatment
Yan-Juan Xiong, Maoyuan Sun, Qingzhu Yang, et al.
Acta Biomaterialia (2025)
Closed Access | Times Cited: 1
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
Moksada Regmi, Yingjie Wang, Weihai Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment
Dongqin Zhou, Yongsheng Li
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 15
A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma
Christopher Cultrara, Christopher Uhl, Kenneth W. Kirby, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e006880-e006880
Open Access | Times Cited: 13
Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma
Junchen Liu, Kun Dai, Muhammad Auwal Saliu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future
Mandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Cancer Letters (2025), pp. 217601-217601
Closed Access
The Complexity of Malignant Glioma Treatment
Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 879-879
Open Access
Preliminary investigation of gut microbiota and associated metabolic pathways in the pathogenesis of primary central nervous system lymphoma
Zhuang Kang, Rong Zhang, Shenglan Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M. Naffaa, Ola A Al-Ewaidat, Sopiko Gogia, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer
Jie Mei, Yun Cai, Lingyan Chen, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 10, pp. 1645-1657
Open Access | Times Cited: 9
Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma
Alberto Repici, Alessio Ardizzone, Fabiola De Luca, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 361-361
Open Access | Times Cited: 3
Role of T Lymphocytes in Glioma Immune Microenvironment: Two Sides of a Coin
Lubna Noor, Arun Upadhyay, Vibhuti Joshi
Biology (2024) Vol. 13, Iss. 10, pp. 846-846
Open Access | Times Cited: 3
Exploring miRNA therapies and gut microbiome–enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting
K. Sandhanam, Tamilanban Thamaraikani, Bedanta Bhattacharjee, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions
Silvia Mara Baez Rodriguez, Ligia Gabriela Tătăranu, A. El Kamel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10765-10765
Open Access | Times Cited: 2
NCDN is a Potential Biomarker and Therapeutic Target for Glioblastoma
Xiaokai Huang, Chengwu Xu, Haipeng Dai, et al.
Journal of Cancer (2024) Vol. 15, Iss. 4, pp. 1067-1076
Open Access | Times Cited: 1
Immunomodulatory R848-Loaded Anti-PD-L1-Conjugated Reduced Graphene Oxide Quantum Dots for Photothermal Immunotherapy of Glioblastoma
Yu‐Jen Lu, Reesha Kakkadavath Vayalakkara, Banendu Sunder Dash, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1064-1064
Open Access | Times Cited: 1
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws
Mohammadmahdi Sabahi, Ali Fathi Jouzdani, Zohre Sadeghian, et al.
Journal of Neuro-Oncology (2024) Vol. 171, Iss. 3, pp. 495-530
Closed Access | Times Cited: 1
Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13614-13614
Open Access | Times Cited: 1
Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
Stefaan Van Gool, Peter Van de Vliet, Linde F. C. Kampers, et al.
Methods in cell biology (2023), pp. 51-113
Closed Access | Times Cited: 2
Identification and Validation of a PEX5-Dependent Signature for Prognostic Prediction in Glioma
Xuhui Qin, Bing Wang, Lu Xia, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 314-314
Open Access
Page 1 - Next Page

Scroll to top